Bridgeway Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bridgeway Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-155,375	Closed	-$120K	–	1469
2022 Q2	$120K	Sell	155,375 -14,525	-9%	-$12.9K	﹤0.01%	1195
2022 Q1	$182K	Hold	169,900	–	–	﹤0.01%	1186
2021 Q4	$323K	Sell	169,900 -26,000	-13%	-$62.3K	0.01%	1087
2021 Q3	$590K	Hold	195,900	–	–	0.01%	987
2021 Q2	$766K	Buy	195,900 +80,000	+69%	+$332K	0.01%	942
2021 Q1	$588K	Hold	115,900	–	–	0.01%	1048
2020 Q4	$474K	Hold	115,900	–	–	0.01%	966
2020 Q3	$563K	Hold	115,900	–	–	0.01%	842
2020 Q2	$642K	Buy	115,900 +35,000	+43%	+$160K	0.01%	789
2020 Q1	$265K	Sell	80,900 -22,400	-22%	-$118K	0.01%	966
2019 Q4	$467K	Hold	103,300	–	–	0.01%	1019
2019 Q3	$430K	Hold	103,300	–	–	0.01%	1011
2019 Q2	$392K	Buy	103,300 +20,000	+24%	+$82K	0.01%	1038
2019 Q1	$349K	Sell	83,300 -43,400	-34%	-$152K	﹤0.01%	1124
2018 Q4	$315K	Hold	126,700	–	–	﹤0.01%	1119
2018 Q3	$925K	Sell	126,700 -25,000	-16%	-$109K	0.01%	912
2018 Q2	$561K	Buy	151,700 +55,000	+57%	+$254K	0.01%	1095
2018 Q1	$372K	Buy	96,700 +4,300	+5%	+$18.1K	﹤0.01%	1160
2017 Q4	$333K	Hold	92,400	–	–	﹤0.01%	1190
2017 Q3	$365K	Hold	92,400	–	–	﹤0.01%	1169
2017 Q2	$471K	Sell	92,400 -42,600	-32%	-$239K	0.01%	1104
2017 Q1	$932K	Buy	135,000 +90,000	+200%	+$703K	0.01%	837
2016 Q4	$421K	Buy	+45,000	New	+$405K	0.01%	1136

Other funds holding AGTC

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bridgeway Capital Management's AGTC Position: Q3 2022 in Review

Bridgeway Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 155,375 shares — an estimated $120K sold.

Bridgeway Capital Management first reported a position in AGTC in Q4 2016 and held it in 23 quarters. The position peaked at $932K in Q1 2017. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

Bridgeway Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
Bridgeway Capital Management sold 155,375 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $120K.
Bridgeway Capital Management first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 23 quarters.
Bridgeway Capital Management's Applied Genetic Technologies Corporation position peaked at $932K in Q1 2017.
45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.